Tin tức & Cập nhật
Lọc theo Chuyên ngành:
Trial of two tenofovir-containing regimens for HIV/HBV co-infection: Insights from ALLIANCE
11 Sep 2024
bởiRoshini Claire Anthony
The triplet combination of bictegravir/emtricitabine/tenofovir alafenamide (B/F/TAF) is as good as dolutegravir + emtricitabine/tenofovir disoproxil fumarate (DTG+F/TDF) in terms of efficacy for HIV control but results in better hepatitis B virus (HBV) outcomes in patients with HIV/HBV co-infection, according to results of the phase III ALLIANCE trial presented at IAS 2022.
Trial of two tenofovir-containing regimens for HIV/HBV co-infection: Insights from ALLIANCE
11 Sep 2024Novel agent plus ritonavir show favourable signals for mild-to-moderate COVID-19
10 Jul 2024
bởiAudrey Abella
A combination regimen comprising the novel agent GST-HG171 (also known as atilotrelvir) and ritonavir improves clinical symptom recovery and viral clearance in low-risk vaccinated adults with mild-to-moderate COVID-19, findings from a pivotal phase II/III study have shown.